{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:01:13Z","timestamp":1781157673626,"version":"3.54.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>We report the case of an 18-year-old previously healthy female who developed acute liver and kidney injuries with cytopenia and hyperinflammatory markers following cytomegalovirus (CMV) infection. Despite not meeting the hemophagocytic lymphohistiocytosis (HLH)-2004 or H-score criteria, her clinical and biochemical profiles suggested an HLH-like syndrome. Whole-exome sequencing revealed a heterozygous dominant stimulator of interferon genes (STING1) (c.841C&amp;gt;T; p. Arg281Trp) mutation. Although the patient lacked classic STING-associated vasculopathy with onset in infancy (SAVI)-associated skin or lung manifestations, immunological profiling revealed an inverted cluster of differentiation (CD)4\/CD8 ratio and absolute CD4+ lymphopenia, supporting a state of underlying immune dysregulation that likely predisposed the patient to severe CMV infection. The patient showed partial clinical and biochemical improvements following antiviral and corticosteroid therapy, supporting our hypothesis of a genetically primed infection-triggered hyper-inflammatory response. This case broadens the STING1 disease spectrum and emphasizes the importance of genomic evaluation of unexplained hyperinflammation, even in apparently immunocompetent hosts. Conclusion: This case highlights a novel STING1 (p. Arg281Trp) gain-of-function mutation with a previously unreported autosomal dominant inheritance pattern identified in both the patient and her asymptomatic father, suggesting incomplete penetrance and variable expression rather than a fully penetrant autosomal dominant pattern. The patient\u2019s presentation was atypical compared with classical SAVI, manifesting as a CMV-triggered HLH-like syndrome with acute renal and liver cell injury in an adolescent with no prior evidence of immune deficiency or family history of genetic disease. Notably, this presentation lacked the characteristic cutaneous and pulmonary involvement. This case highlights a distinct phenotypic spectrum and expands our understanding of STING1-related interferonopathies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1801755","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:47:06Z","timestamp":1781156826000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Genetically primed hyperinflammation: cytomegalovirus-triggered HLH-like syndrome in an adolescent with a gain-of-function STING1 (p.Arg281Trp) variant with novel autosomal dominant inheritance and atypical presentation"],"prefix":"10.3389","volume":"17","author":[{"given":"Ehab Abdelbadeeh Hassan","family":"Hammad","sequence":"first","affiliation":[{"name":"Adult Transplant Nephrology, Kidney and Pancreas Health Centre, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]},{"name":"Department of Internal Medicine and Nephrology, Faculty of Medicine, Fayoum University","place":["Fayoum, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq Zulfiquar","family":"Ali","sequence":"additional","affiliation":[{"name":"Adult Transplant Nephrology, Kidney and Pancreas Health Centre, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter Clemens","family":"Broering","sequence":"additional","affiliation":[{"name":"Organ Transplant Centre of Excellence, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Ali","family":"Aleid","sequence":"additional","affiliation":[{"name":"Adult Transplant Nephrology, Kidney and Pancreas Health Centre, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quaid Johar","family":"Nadri","sequence":"additional","affiliation":[{"name":"Adult Transplant Nephrology, Kidney and Pancreas Health Centre, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab Salah Fathy","family":"Nasr","sequence":"additional","affiliation":[{"name":"Adult Transplant Nephrology, Kidney and Pancreas Health Centre, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]},{"name":"Department of Internal Medicine and Nephrology, Faculty of Medicine, Benha University","place":["Benha, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232167","article-title":"A novel STING variant triggers endothelial toxicity and SAVI disease","volume":"221","author":"Valeri","year":"2024","journal-title":"J Exp Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1818281116","article-title":"Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models","volume":"116","author":"Motwani","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jaci.2016.10.031","article-title":"Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling","volume":"140","author":"Melki","year":"2017","journal-title":"J Allergy Clin Immun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636225","article-title":"Case report: Novel SAVI-causing variants in STING1 expand the clinical disease spectrum and suggest a refined model of STING activation","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.109896","article-title":"Clinical heterogeneity in families with multiple cases of inborn errors of immunity","volume":"259","author":"Delavari","year":"2024","journal-title":"Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1183142","article-title":"Nature and nurture: understanding phenotypic variation in inborn errors of immunity","volume":"13","author":"Similuk","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaci.2019.09.009","article-title":"Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology","volume":"145","author":"Chinn","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.11.007","article-title":"Advances and challenges of the decade: The ever-changing clinical and genetic landscape of immunodeficiency","volume":"11","author":"Walter","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxad001","article-title":"Not too little, not too much: the impact of mutation types in Wiskott-Aldrich syndrome and RAC2 patients","volume":"212","author":"Hsu","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1020927","article-title":"Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience","volume":"13","author":"Urdinez","year":"2022","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.11.051","article-title":"Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations","volume":"146","author":"Lorenzini","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825367","article-title":"Janus kinase inhibitors in the treatment of type I interferonopathies: A case series from a single center in China","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1615075","article-title":"Response to two Janus kinase inhibitors in a boy with SAVI during 2-year follow-up: case report and literature review","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00645-0","article-title":"Efficacy and adverse events during Janus kinase inhibitor treatment of SAVI syndrome","volume":"39","author":"Volpi","year":"2019","journal-title":"J ClinImmunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031832","article-title":"Use of tofacitinib for infant-onset STING-associated vasculopathy: A case report from China","volume":"101","author":"Shen","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.599564","article-title":"A novel biallelic STING1 gene variant causing SAVI in two siblings","volume":"11","author":"Alghamdi","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1029423","article-title":"Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases","volume":"13","author":"Wan","year":"2022","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-025-09670-1","article-title":"Severe interstitial lung disease as the first manifestation of a variant in a familial case","volume":"73","author":"Kang","year":"2025","journal-title":"Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.molimm.2026.02.008","article-title":"Emerging molecular mechanisms of cGAS-STING activation and regulation","volume":"193","author":"Liu","year":"2026","journal-title":"Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1146\/annurev-biochem-040320-101629","article-title":"Biochemistry, cell biology, and pathophysiology of the innate immune cGAS-cGAMP-STING pathway","volume":"91","author":"Ritchie","year":"2022","journal-title":"Annu Rev Biochem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","article-title":"Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients","volume":"9","author":"Fr\u00e9mond","year":"2021","journal-title":"J Aller Cl Imm-Pract"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.42087","article-title":"The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE\/PRAAS, SAVI, and AGS","volume":"74","author":"Gedik","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1692365","article-title":"Molecular mechanisms and therapeutic strategies of cGAS-STING pathway in liver disease: the quest continues","volume":"16","author":"Fan","year":"2025","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.682736","article-title":"The cGAS-STING pathway: novel perspectives in liver diseases","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2025.12.001","article-title":"Emerging mechanistic roles of STING signaling in kidney diseases","volume":"196","author":"Gu","year":"2026","journal-title":"Am J Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.178155","article-title":"The cGAS-STING axis in kidney disease: mechanisms and therapeutic potential","volume":"1006","author":"Li","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2023.08.025","article-title":"STING promotes ferroptosis through NCOA4-dependent ferritinophagy in acute kidney injury","volume":"208","author":"Jin","year":"2023","journal-title":"Free Radical Bio Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01806-18","article-title":"A human gain-of-function STING mutation causes immunodeficiency and gammaherpesvirus-induced pulmonary fibrosis in mice","volume":"93","author":"Bennion","year":"2019","journal-title":"J Virol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2025.110493","article-title":"A novel-activating mutation is identified in a patient with childhood-onset systemic lupus erythematosus","volume":"276","author":"Li","year":"2025","journal-title":"Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005546","article-title":"cGAS senses human cytomegalovirus and induces type I interferon responses in human monocyte-derived cells","volume":"12","author":"Paijo","year":"2016","journal-title":"PloS Pathog"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/Jvi.01040-16","article-title":"cGAS-STING signaling regulates initial innate control of cytomegalovirus infection","volume":"90","author":"Lio","year":"2016","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01048-25","article-title":"The BTK-DDX41 axis of the STING pathway is activated during cytomegalovirus lytic infection","volume":"99","author":"Baruah","year":"2025","journal-title":"J Virol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:47:10Z","timestamp":1781156830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2026.1801755"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1801755","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"article-number":"1801755"}}